SFRP2 and ductal breast carcinoma in situ: For example, if we examined sufficient cases of patient DCIS or animal models and found that high expression of TGF-α, PKMYT1 and decreased SFRP1 and SFRP2 in the stroma were associated with disease recurrence, invasive disease or decreased survival, these data could indicate predictive value for these markers.